KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia.
| Image |  |
|---|---|
| Description | scientific article published on 04 February 2013 |
| Author/s |
author: Andrew L. Kung Marc Mansour Joan Montero A. Thomas Look Alex Kentsis Anthony Letai Takaomi Sanda |
| Publication date | February 4, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |